RESÚMENES SEPTIEMBRE 2005

.

Child & Adolescent Disorders

(Requiere estar conectado a internet. Haga un click en la información del journal)

 

Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders
Hardan AY, Jou RJ, Handen BL

J Autism Dev Disord. 2005 Jun;35(3):387-91

 

Fronto-parietal activation in attention-deficit hyperactivity disorder, combined type: functional magnetic resonance imaging study

T. Silk, A. Vance, N. Rinehart, G. Egan, M. O’Boyle, J. L. Bradshaw, R. Cunnington

The British Journal of Psychiatry (2005) 187: 282-283

Altered Neural Substrates of Cognitive Control in Childhood ADHD: Evidence From Functional Magnetic Resonance Imaging

Chandan J. Vaidya, Silvia A. Bunge, Nicole M. Dudukovic, Christine A. Zalecki, Glen R. Elliott, and John D.E. Gabrieli

Am J Psychiatry 162:1605-1613, September 2005

The Genetic and Environmental Contributions to Attention Deficit Hyperactivity Disorder as Measured by the Conners’ Rating Scales—Revised

James J. Hudziak, Eske M. Derks, Robert R. Althoff, David C. Rettew, and Dorret I. Boomsma

Am J Psychiatry 162:1614-1620, September 2005

Cost-Effectiveness of ADHD Treatments: Findings From the Multimodal Treatment Study of Children With ADHD

Peter S. Jensen, Joe Albert Garcia, Sherry Glied, Maura Crowe, Mike Foster, Michael Schlander, Stephen Hinshaw, Benedetto Vitiello, L. Eugene Arnold, Glen Elliott, Lily Hechtman, Jeffrey H. Newcorn, William E. Pelham, James Swanson, Karen Wells

Am J Psychiatry 162:1628-1636, September 2005

Cingulate Cortex Anatomical Abnormalities in Children and Adolescents With Bipolar Disorder

Simerjit Kaur, Roberto B. Sassi, David Axelson, Mark Nicoletti, Paolo Brambilla, E. Serap Monkul, John P. Hatch, Matcheri S. Keshavan, Neal Ryan, Boris Birmaher, Jair C. Soares

Am J Psychiatry 162:1637-1643, September 2005

The effectiveness of atomoxetine in children, adolescents, and adults with ADHD A systematic overview
Sevecke K, Battel S, Dittmann RW, Lehmkuhl G, Dopfner M

Nervenarzt. 2005 Aug 20; [Epub ahead of print]

 

Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents
Purper-Ouakil D, Fourneret P, Wohl M, Reneric JP

Encephale. 2005 May-Jun;31(3):337-48

 

Selective serotonin reuptake inhibitors in Major Depressive Disorder in children and adolescents (ratio of benefits/risks)
Hjalmarsson L, Corcos M, Jeammet P

Encephale. 2005 May-Jun;31(3):309-16

 

Dopamine transporter in attention-deficit hyperactivity disorder normalizes after cessation of methylphenidate
Feron FJ, Hendriksen JG, van Kroonenburgh MJ, Blom-Coenjaerts C, Kessels AG, Jolles J, Weber WE, Vles JS

Pediatr Neurol. 2005 Sep;33(3):179-83

 

Global and regional gray matter reductions in ADHD: A voxel-based morphometric study

S. Carmona, O. Vilarroya, A. Bielsa, V. Trèmols, J.C. Soliva, M. Rovira, J. Tomàs, C. Raheb, J.D. Gispert, S. Batlle and A. Bulbena

Neuroscience Letters. Volume 389, Issue 2, 2 December 2005, Pages 88-93

 

Tetrahydrobiopterin in the Treatment of Children With Autistic Disorder: A Double-blind Placebo-Controlled Crossover Study
Danfors, Torsten; von Knorring, Anne-Liis; Hartvig, Per; Langstrom, Bengt; Moulder, Robert; Stromberg, Bo; Torstenson, Richard; Wester, Ulrika; Watanabe, Yasuyoshi; Eeg-Olofsson, Orvar

Journal of Clinical Psychopharmacology. 25(5):485-489, October 2005

Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders

O. Dinca, M. Paul, N. J. Spencer

Journal of Psychopharmacology, Vol. 19, No. 5, 521-532 (2005)

Metabolic side effects of atypical antipsychotics in children: a literature review

Valérie J. Fedorowicz, Eric Fombonne

Journal of Psychopharmacology, Vol. 19, No. 5, 533-550 (2005)

10-Year Research Update Review: The Epidemiology of Child and Adolescent Psychiatric Disorders: I. Methods and Public Health Burden
Costello, E Jane; Egger, Helen; Angold, Adrian

Journal of the American Academy of Child & Adolescent Psychiatry. 44(10):972-986, October 2005

ADHD Treatment With Once-Daily OROS Methylphenidate: Final Results From a Long-Term Open-Label Study
Wilens, Timothy; MCBurnett, Keith; Stein, Mark; Lerner, Marc; Spencer, Thomas; Wolraich, Mark

Journal of the American Academy of Child & Adolescent Psychiatry. 44(10):1015-1023, October 2005

Hematological Adverse Events in Clozapine-Treated Children and Adolescents
Gerbino-Rosen, Ginny; Roofeh, David; Tompkins, D Andrew; Feryo, Doug; Nusser, Laurie; Kranzler, Harvey; Napolitano, Barbara; Frederickson, Anne; Henderson, Inika; Rhinewine, Joe; Kumra, Sanjiv

Journal of the American Academy of Child & Adolescent Psychiatry. 44(10):1024-1031, October 2005

 

Effect of Carbamazepine on Serum Lipids and Liver Function Tests

Anju Aggarwal, Manish Kumar and M.M.A Faridi

INDIAN PEDIATRICS. VOLUME 42; SEPTEMBER 17, 2005: 913

 

Depression in children and young people. dentification and management in primary, community and secondary care

National Collaborating Centre for Mental Health

Clinical Guideline 28, September 2005

.

Regresar a RESÚMENES SEPTIEMBRE 2005